Nanogen Issued Patent for Enhancing Molecular Biological Reactions

August 25, 2004

Nanogen, Inc., developer of molecular and point-of-care diagnostic products, announced today that it was issued U.S. Patent No. 6,780,584, "Electronic Systems and Component Devices for Macroscopic and Microscopic Molecular Biological Reactions, Analyses and Diagnostics," by the U.S. Patent and Trademark Office. The '584 patent covers the design, development, and capability of an electronic system to carry out and control multi-step and multiplex reactions in macroscopic or microscopic formats. The system described in the patent is at the core of Nanogen's electronic microarray technology, which uses electricity to move and concentrate biological samples in miniature formats for diagnostic applications.

The '584 patent covers technology that controls biological reactions by managing the localized concentration of two or more reaction-dependant molecules and their reaction environment. This approach greatly enhances the rate and specificity of the molecular biological reaction, as evidenced by the Nanogen microarray's ability to accelerate molecular binding up to 1,000 times faster than traditional passive methods. The technology described in this broad patent enables control over a wide range of molecular reactions involved in molecular analyses and diagnostics, including nucleic acid hybridizations and amplification, antibody and antigen reactions, and more.

"Nanogen's unique approach of integrating sophisticated microelectronics and molecular biology made the NanoChip(R) Electronic Microarray the first to be used in developing fast and accurate molecular diagnostic tests," said Howard C. Birndorf, Nanogen chairman and chief executive officer. "With the issuance of patent '584, Nanogen increases its intellectual property portfolio enabling the continued development and commercialization of advanced diagnostics that provide physicians and patients valuable healthcare information."

Source: Nanogen

Explore further: Researchers successfully use Parsortix system in ovarian cancer drug trials

Related Stories

Chemists invent new supercapacitor materials

June 13, 2016

Dr David Eisenberg and Prof. Gadi Rothenberg of the University of Amsterdam's Van 't Hoff Institute for Molecular Sciences have invented a new type of supercapacitor material with a host of potential applications in electronics, ...

Scientists engineer tunable DNA for electronics applications

June 20, 2016

DNA may be the blueprint of life, but it's also a molecule made from just a few simple chemical building blocks. Among its properties is the ability to conduct an electrical charge, making one of the hottest areas in engineering ...

A better test for a potato pest

August 23, 2011

A U.S. Department of Agriculture (USDA) scientist has created a new weapon in the war being waged against the potato cyst nematode-a diagnostic test that identifies the type of nematode infesting a grower's field.

Patent solution in a canning jar

August 12, 2014

From shopping bags to shampoo bottles to plastic watering cans – many everyday objects both large and small might look very different if it hadn't been for the invention of chemist and Max Planck researcher Karl Ziegler. ...

Recommended for you

Rosetta captures comet outburst

August 25, 2016

In unprecedented observations made earlier this year, Rosetta unexpectedly captured a dramatic comet outburst that may have been triggered by a landslide.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.